DB:0T01

Stock Analysis Report

Executive Summary

TILT Holdings Inc., a vertically-integrated technology and infrastructure company, engages in the provision of various products and services in the cannabis industry.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.

Share Price & News

How has TILT Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-31.9%

0T01

2.4%

DE Pharmaceuticals

3.9%

DE Market


1 Year Return

n/a

0T01

-4.4%

DE Pharmaceuticals

3.4%

DE Market


Shareholder returns

0T01IndustryMarket
7 Day-31.9%2.4%3.9%
30 Day-34.3%2.4%2.1%
90 Dayn/a11.2%3.7%
1 Yearn/a-1.1%-4.4%6.7%3.4%
3 Yearn/a-4.9%-12.8%18.9%8.6%
5 Yearn/a-3.1%-15.1%41.8%22.5%

Price Volatility Vs. Market

How volatile is TILT Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is TILT Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: 0T01 (€1.26) is trading below our estimate of fair value (€120.98)

Significantly Undervalued: 0T01 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 0T01 is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.

PE vs Market: 0T01 is unprofitable, so we can't compare its PE Ratio to the German market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate 0T01's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 0T01 is good value based on its PB Ratio (0.3x) compared to the DE Pharmaceuticals industry average (2.6x).


Next Steps

Future Growth

How is TILT Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

132.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0T01 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0T01 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0T01 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0T01's revenue (96.6% per year) is forecast to grow faster than the German market (5% per year).

High Growth Revenue: 0T01's revenue (96.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has TILT Holdings performed over the past 5 years?

-10536.7%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 0T01 is unprofitable, and there is insufficient past data to establish if their past 5-year earnings growth rate was positive.

Accelerating Growth: Unable to compare 0T01's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0T01 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (0.4%).


Return on Equity

High ROE: 0T01 has a negative Return on Equity (-272.16%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: 0T01 is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: 0T01 is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is TILT Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 0T01's short term assets (CA$125.6M) exceeds its short term liabilities (CA$16.3M)

Long Term Liabilities: 0T01's short term assets (125.6M) exceeds its long term liabilities (1.7M)


Debt to Equity History and Analysis

Debt Level: 0T01 is debt free.

Reducing Debt: 0T01 has not had any debt for past 5 years.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0T01 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 0T01 has sufficient cash runway for 1.083003 years if free cash flow continues to reduce at historical rates of -108.9% each year.


Next Steps

Dividend

What is TILT Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage2.8%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 0T01's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 0T01's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 0T01's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 0T01's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 0T01's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

What is the CEO of TILT Holdings's salary, the management and board of directors tenure and is there insider trading?


CEO

Alex Coleman 0

0.5yrs

Tenure

0

Mr. Alexander Coleman, also known as Alex, serve as Chief Executive Officer and Co-Chairman of TILT Holdings Inc. (Formerly Santé Veritas Holdings Inc.) Prior to co-founding Sea Hunter in 2017, Mr. Colema ...


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Joel Milton

    Senior Vice President of Business Development

    • Tenure: 0yrs
  • Alex Coleman

    CEO & Co-Chairman

    • Tenure: 0.5yrs
  • Robert Leidy

    Senior Vice President of Business Development

    • Tenure: 0yrs
  • Geoff Hamm

    Senior VP of Operations & Director

    • Tenure: 0yrs
  • Lars Vaule

    Chief Operating Officer

    • Tenure: 0yrs
  • David Caloia

    Chief Financial Officer

    • Tenure: 0.3yrs

Board Members

  • Gary Smith

    Director

    • Tenure: 0.3yrs
  • Michael Orr

    Co-Chairman

    • Tenure: 0yrs
  • Todd Halpern

    Director

    • Tenure: 0yrs
  • Alex Coleman

    CEO & Co-Chairman

    • Tenure: 0.5yrs
  • Geoff Hamm

    Senior VP of Operations & Director

    • Tenure: 0yrs

Company Information

TILT Holdings Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: TILT Holdings Inc.
  • Ticker: 0T01
  • Exchange: DB
  • Founded:
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$277.729m
  • Listing Market Cap: CA$184.300m
  • Shares outstanding: 133.52m
  • Website: https://www.tiltholdings.com

Location

  • TILT Holdings Inc.
  • 745 Thurlow Street
  • Suite 2400
  • Vancouver
  • British Columbia
  • V6C 0C5
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TILTCNSX (Canadian National Stock Exchange)YesCommon SharesCACADApr 2018
0T01DB (Deutsche Boerse AG)YesCommon SharesDEEURApr 2018

Biography

TILT Holdings Inc., a vertically-integrated technology and infrastructure company, engages in the provision of various products and services in the cannabis industry. It focuses on the production and deliv ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/05/08 22:33
End of Day Share Price2019/05/08 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.